MedTrace Logo

Communicating Risk Information for Obesity

NCT01355224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 798

Last updated 2017-03-14

Study results available
· View outcomes & findings →

Summary

This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.

Conditions

Interventions

GENETIC

Genetic

Relative risk estimates will be presented based on individuals' risk for obesity based on FTO genotype results.

BEHAVIORAL

Lifestyle

Relative risk estimates will be presented based on individuals' risk for obesity due to lifestyle factors.

Sponsors & Collaborators

  • Boston University

    lead OTHER

  • National Human Genome Research Institute (NHGRI)

    collaborator NIH

Principal Investigators

  • Catharine Wang, PhD, MSc · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01355224 on ClinicalTrials.gov